The insurance giant’s C-suite is getting leaner at precisely the moment its balance sheet is bulging. Allianz has confirmed that Günther Thallinger will step down from the board at the end of 2026, reducing the executive team from nine to eight members from the 2026/2027 turn of the year. His departure follows the earlier announced retirement of Klaus-Peter Röhler, who leaves after three decades with the company.
The timing is no coincidence. Allianz is simultaneously executing one of its most ambitious geographic expansions in years, and the boardroom refresh is designed to align leadership responsibilities with that push. Tomas Kunzmann, currently at the helm of the Allianz Partners division, will join the board on 1 January 2027, taking charge of the Asia-Pacific region, global health insurance and sustainability. Andreas Wimmer assumes responsibility for investment management, while Renate Wagner picks up Germany, Switzerland and Central Europe.
A Shopping Spree Funded by Operating Muscle
The leadership reshuffle lands as Allianz deploys its capital strength into targeted acquisitions rather than returning every euro to shareholders. Late July brought a landmark agreement with HSBC to acquire HSBC Life Singapore for €2 billion, coupled with a 15-year distribution partnership with the British lender. The transaction is slated to close in the first half of 2027, with Allianz guiding to double-digit returns on the deal over the medium term.
Europe has not been overlooked. The group also agreed to purchase Portuguese insurer Caravela from Toscaf and other investors for roughly €150 million, lifting its market share in Portugal to 6.4 per cent. Regulatory clearance from Portugal’s ASF and the competition authority remains pending.
Record Quarter Provides the Foundation
None of this expansion would carry much weight without the numbers to back it, and on that front Allianz delivered. The second quarter of 2026 produced record operating profit of €4.874 billion, up 10.6 per cent year on year. The picture on net income was less flattering — adjusted quarterly profit fell 12.7 per cent, a decline the company attributes to the base effect from the 2025 UniCredit sale and restructuring costs tied to Indian joint ventures.
The full-year target of €17.4 billion in operating profit, with a tolerance of plus or minus €1 billion, was reaffirmed in early August. The first half contributed €9.4 billion to that goal, against €8.6 billion in the comparable period of 2025.
Should investors sell immediately? Or is it worth buying Allianz?
Capital strength has improved alongside earnings. The Solvency II ratio climbed to 225 per cent from 218 per cent at the end of 2025, while share buybacks returned €1.4 billion to investors in the first six months of the year. That combination of growing profits and a comfortable capital cushion helps explain why investors have taken the board changes largely in stride.
Asset Management Adds to the Momentum
The group’s fund arm also turned in a solid performance. Third-party net inflows reached €39 billion in the second quarter, beating the €35 billion analysts had pencilled in. Assets under management stood at €2.161 trillion, while the division’s operating profit advanced 19.7 per cent to €933 million.
The broader industry backdrop offers little cause for concern either. In late August, the German Insurance Association (GDV) signalled expectations of comparatively low natural catastrophe losses, a factor that could limit the drag from major claims events — though no company-specific figure was attached to that outlook.
Shares Hug Their Highs
The market’s verdict on this confluence of boardroom change and operational strength is visible in the share price. The stock closed Friday at €451.20, a mere 0.7 per cent below its 52-week high of €454.50 set in early September. The shares have gained 15 per cent since the start of the year and 27 per cent over twelve months, trading comfortably above the 200-day moving average of €390.59.
Investors will get their next read on how the new structure is holding up when third-quarter results land on 12 November. Between now and then, the integration of fresh acquisitions and the parallel leadership transition will test whether Allianz can keep its operational engine running smoothly while the people at the top settle into their new seats.
Ad
Allianz Stock: Buy or Sell?! New Allianz Analysis from September 5 delivers the answer:
The latest Allianz figures speak for themselves: Urgent action needed for Allianz investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 5.
Allianz: Buy or sell? Read more here...










